You are here

Hawaii Biotech, Inc.

Company Information
Address 650 Iwilei Rd Ste 204
Honolulu, HI, 96817-5318


Information

DUNS: 113226823

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Cross-Protective Multivalent Vaccine for Tick-Borne Flaviviruses

    Amount: $839,920.00

    Project Summary AbstractThe NIH NIAIDStrategic Plan is specifically directed at promoting research that can provide solutions to mitigate the threat posed by emerging and re emerging diseasesThe tick ...

    SBIRPhase II2019Department of Health and Human Services National Institutes of Health
  2. Chikungunya Recombinant Subunit Vaccine

    Amount: $600,000.00

    DESCRIPTION provided by applicant Chikungunya virus CHIKV is an alphavirus classified as a category C priority pathogen that causes fever rash and arthralgia in humans In the past decade CHI ...

    SBIRPhase I2016Department of Health and Human Services National Institutes of Health
  3. Novel Adjuvants to Enhance the Immunogenicity of a Dengue Vaccine

    Amount: $99,888.00

    Dengue virus (DENV) is a mosquito-borne flavivirus that poses a tremendous public health threat throughout the world. The U.S. military has also been challenged by dengue for over a hundred years and ...

    SBIRPhase I2015Department of Defense Army
  4. Cross-Protective Multivalent Vaccine for Tick-Borne Flaviviruses

    Amount: $2,113,306.00

    DESCRIPTION provided by applicant The tick borne flavivirus TBFV group includes a number of important human pathogens that result in serious encephalitic or hemorrhagic diseases that are either ...

    SBIRPhase II2015Department of Health and Human Services
  5. Development of a Recombinant Subunit Vaccine for CCHF

    Amount: $530,899.00

    DESCRIPTION (provided by applicant): Emerging and reemerging infectious diseases continue to pose serious health threats world-wide. Consequently, the development of measures to mitigate the natural, ...

    SBIRPhase I2012Department of Health and Human Services
  6. Recombinant Subunit Vaccine For Tick-Borne Encephalitis

    Amount: $2,983,510.00

    DESCRIPTION (provided by applicant): Tick-borne encephalitis (TBE) is a neurological disease caused by Flaviviruses of the tick-borne encephalitis group and causes death in up to 60% of the individua ...

    SBIRPhase II2009Department of Health and Human Services
  7. Discovery of West Nile Virus Protease Inhibitors

    Amount: $999,975.00

    DESCRIPTION (provided by applicant): The strain of West Nile virus now endemic in the continental United States is more virulent than the virus originally isolated in Africa and is classified as a cat ...

    SBIRPhase I2006Department of Health and Human Services
  8. Structure Based Design of Dengue Virus Fusion Inhibitors

    Amount: $797,650.00

    DESCRIPTION (provided by applicant): Over half of the world population is at risk for infection by dengue virus, a mosquito borne member of the Flavivirus family that consists of four distinct serotyp ...

    SBIRPhase I2006Department of Health and Human Services
  9. Optimization of Small Molecule Botulinum Neurotoxin Inhibitors

    Amount: $1,019,210.00

    DESCRIPTION (provided by applicant): Medicinal and computational chemistry methods will be used to optimize validated hit compounds found to inhibit botulinum neurotoxin. These inhibitors, discovered ...

    SBIRPhase I2006Department of Health and Human Services
  10. Recombinant Subunit Protein for Flu Vaccine

    Amount: $979,908.00

    DESCRIPTION (provided by applicant): Current influenza vaccine production procedures (use of embryonated chicken eggs) inherently limit the amount of influenza vaccine that can be produced prior to e ...

    SBIRPhase I2005Department of Health and Human Services
US Flag An Official Website of the United States Government